Levothyroxine Sodium
Pricing Report NDC 0527-4956-32

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Levothyroxine Sodium (NDC 0527-4956-32) is $2.83213 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 21, 2025.

As a provided by Lannett Company, Inc., this medication is distributed in a 3 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$2.83213
Per EA

Effective Date
May 21, 2025
Data Status
As of Oct 29, 2025
C/I - Chain or Independent Pharmacy
Package NDC
Description
3 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2022, the NADAC wholesale price for (NDC ) has moved within a range of $2.04843 to $4.07527 per EA. Over this 2 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$2.0484 - $4.0753
Market Volatility
98.95% Variance
Latest Trend
No Change
Date Unit Price Unit Source Method Rate
May 21, 2025 $2.83213 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2025 $2.83213 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Apr 23, 2025 $2.83213 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $2.83213 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2025 $2.91178 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2025 $3.08599 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $3.07289 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2024 $3.35477 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2024 $2.79282 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 18, 2024 $2.65383 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2024 $2.51797 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 17, 2024 $2.51797 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 19, 2024 $2.40815 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 22, 2024 $2.04843 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 17, 2024 $2.98200 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 22, 2023 $4.07527 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 22, 2023 $4.07527 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Sep 21, 2022 $3.83428 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 21, 2022 $3.83428 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026